相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vacuolin-1 inhibits endosomal trafficking and metastasis via CapZβ
Zuodong Ye et al.
ONCOGENE (2021)
Capping protein regulates endosomal trafficking by controlling F-actin density around endocytic vesicles and recruiting RAB5 effectors
Dawei Wang et al.
ELIFE (2021)
Energy status dictates PD-L1 protein abundance and anti-tumor to enable blockade
Xiaoming Dai et al.
MOLECULAR CELL (2021)
The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
Yanyan Tang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytotoxic T cells swarm by homotypic chemokine signalling
Jorge Luis Galeano Nino et al.
ELIFE (2020)
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours
Han Yao et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio et al.
CELL (2019)
Interfering with endolysosomal trafficking enhances release of bioactive exosomes
Francisco G. Ortega et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Exosomes and autophagy: rekindling the vesicular waste hypothesis
Johann Mar Gudbergsson et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2019)
The role of exosomal PD-L1 in tumor progression and immunotherapy
Feiting Xie et al.
MOLECULAR CANCER (2019)
Mechanisms Controlling PD-L1 Expression in Cancer
Jong-Ho Cha et al.
MOLECULAR CELL (2019)
Palmitoylation stabilizes PD-L1 to promote breast tumor growth
Yi Yang et al.
CELL RESEARCH (2019)
HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity
Huanbin Wang et al.
NATURE CHEMICAL BIOLOGY (2019)
Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
Yi Yang et al.
CELL RESEARCH (2018)
Oncogenic pathways that affect antitumor immune response and immune checkpoint blockade therapy
Xianda Zhao et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen et al.
NATURE (2018)
Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
Marie-Nicole Theodoraki et al.
CLINICAL CANCER RESEARCH (2018)
Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer
Zishuo I. Hu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Identification of Novel Vacuolin-1 Analogues as Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis
Chang Chen et al.
MOLECULES (2017)
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra et al.
NATURE (2017)
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Marian L. Burr et al.
NATURE (2017)
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
DQ-Red BSA Trafficking Assay in Cultured Cells to Assess Cargo Delivery to Lysosomes
Rituraj Marwaha et al.
BIO-PROTOCOL (2017)
Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
Jian Guan et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
Haidong Tang et al.
CANCER CELL (2016)
Genomic Approaches to Understanding Response and Resistance to Immunotherapy
David A. Braun et al.
CLINICAL CANCER RESEARCH (2016)
A meta-analysis of efficacy and safety of antibodies targeting PD-1/PD-L1 in treatment of advanced nonsmall cell lung cancer
Cuihua Wang et al.
MEDICINE (2016)
Association of PD-1/PD-L axis expression with cytolytic activity, mutational load, and prognosis in melanoma and other solid tumors
Ludmila Danilova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A
Yingying Lu et al.
AUTOPHAGY (2014)
Manipulating the lateral diffusion of surface-anchored EGF demonstrates that receptor clustering modulates phosphorylation levels
D. Stabley et al.
INTEGRATIVE BIOLOGY (2013)
Maturing reticulocytes internalize plasma membrane in glycophorin A-containing vesicles that fuse with autophagosomes before exocytosis
Rebecca E. Griffiths et al.
BLOOD (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
A practical guide to evaluating colocalization in biological microscopy
Kenneth W. Dunn et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
Carol M. Lee et al.
BMC CANCER (2010)
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Nobuyoshi Kosaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling
Arthit Chairoungdua et al.
JOURNAL OF CELL BIOLOGY (2010)
Rab27a and Rab27b control different steps of the exosome secretion pathway
Matias Ostrowski et al.
NATURE CELL BIOLOGY (2010)
Tumor-derived chemokine MCP-1/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells
Christine E. Brown et al.
JOURNAL OF IMMUNOLOGY (2007)
Nerve growth factor-mediated neurite outgrowth via regulation of Rab5
Jay Liu et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Rab conversion as a mechanism of progression from early to late endosomes
J Rink et al.
CELL (2005)
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
LP Chen
NATURE REVIEWS IMMUNOLOGY (2004)
The small chemical vacuolin-1 inhibits Ca2+-dependent lysosomal exocytosis but not cell resealing
J Cerny et al.
EMBO REPORTS (2004)
Expression of Fas ligand is not a main mechanism used by tumors to counteract antitumor immunity
CM Chen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells
H Vincent-Schneider et al.
INTERNATIONAL IMMUNOLOGY (2002)
Slac2-a/melanophilin, the missing link between Rab27 and myosin Va - Implications of a tripartite protein complex for melanosome transport
M Fukuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
